Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sandra Bohn Thomsen"'
Autor:
Marianne Kiszka-Kanowitz, Klaus Theede, Sandra Bohn Thomsen, Jacob Tveiten Bjerrum, Jørn Brynskov, Ida Benedikte Gottschalck, Elena Akimenko, Karen Lisa Hilsted, Anders Neumann, Signe Wildt, Lone Larsen, Jens Kristian Munk, Per Holger Ibsen, Huma Gul Rehana Janjua, Lise Lotte Gluud, Anette Mertz-Nielsen
Publikováno v:
EClinicalMedicine, Vol 45, Iss , Pp 101332- (2022)
Summary: Background: Retrospective studies suggest that for patients with ulcerative colitis (UC) combination therapy with low-dose azathioprine and allopurinol (L-AZA/ALLO) may result in higher remission rates than monotherapy with azathioprine (AZA
Externí odkaz:
https://doaj.org/article/97e99eefbcd243a1995ac82e77994a54
Autor:
Sandra Bohn Thomsen, Ryan C. Ungaro, Kristine H. Allin, Rahma Elmahdi, Gry Poulsen, Mikael Andersson, Jean‐Frederic Colombel, Tine Jess
Publikováno v:
Thomsen, S B, Ungaro, R C, Allin, K H, Elmahdi, R, Poulsen, G, Andersson, M, Colombel, J-F & Jess, T 2022, ' Impact of thiopurine discontinuation at anti-tumour necrosis factor initiation in inflammatory bowel disease treatment : a nationwide Danish cohort study ', Alimentary Pharmacology & Therapeutics, vol. 55, no. 9, pp. 1128-1138 . https://doi.org/10.1111/apt.16777
BACKGROUND: Escalation to anti-tumour necrosis factor (anti-TNF) in inflammatory bowel disease (IBD) patients on thiopurine is a common clinical scenario. However, the impact of discontinuing thiopurine at escalation is unclear.AIM: To assess the imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d5a08cf15ceda0cc8b8204820847da0
https://doi.org/10.1111/apt.16777
https://doi.org/10.1111/apt.16777
Autor:
Marianne Kiszka-Kanowitz, Klaus Theede, Sandra Bohn Thomsen, Jacob Tveiten Bjerrum, Jørn Brynskov, Ida Benedikte Gottschalck, Elena Akimenko, Karen Lisa Hilsted, Anders Neumann, Signe Wildt, Lone Larsen, Jens Kristian Munk, Per Holger Ibsen, Huma Gul Rehana Janjua, Lise Lotte Gluud, Anette Mertz-Nielsen
Publikováno v:
Kiszka-Kanowitz, M, Theede, K, Thomsen, S B, Bjerrum, J T, Brynskov, J, Gottschalck, I B, Akimenko, E, Hilsted, K L, Neumann, A, Wildt, S, Larsen, L, Munk, J K, Ibsen, P H, Janjua, H G R, Gluud, L L & Nielsen, A M 2022, ' Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial ', EClinicalMedicine, vol. 45, 101332 . https://doi.org/10.1016/j.eclinm.2022.101332
Kiszka-Kanowitz, M, Theede, K, Thomsen, S B, Bjerrum, J T, Brynskov, J, Gottschalck, I B, Akimenko, E, Hilsted, K L, Neumann, A, Wildt, S, Larsen, L, Munk, J K, Ibsen, P H, Janjua, H G R, Gluud, L L & Mertz-Nielsen, A 2022, ' Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC) : An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial ', EClinicalMedicine, vol. 45, 101332 . https://doi.org/10.1016/j.eclinm.2022.101332
Kiszka-Kanowitz, M, Theede, K, Thomsen, S B, Bjerrum, J T, Brynskov, J, Gottschalck, I B, Akimenko, E, Hilsted, K L, Neumann, A, Wildt, S, Larsen, L, Munk, J K, Ibsen, P H, Janjua, H G R, Gluud, L L & Mertz-Nielsen, A 2022, ' Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC) : An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial ', EClinicalMedicine, vol. 45, 101332 . https://doi.org/10.1016/j.eclinm.2022.101332
Background: Retrospective studies suggest that for patients with ulcerative colitis (UC) combination therapy with low-dose azathioprine and allopurinol (L-AZA/ALLO) may result in higher remission rates than monotherapy with azathioprine (AZA). We pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b9f76555ea753d957889bc724b3741a
https://vbn.aau.dk/da/publications/61c3cd43-3e43-4958-a918-97d2a63c25e7
https://vbn.aau.dk/da/publications/61c3cd43-3e43-4958-a918-97d2a63c25e7
Autor:
Kristine H. Allin, Johan Burisch, Tine Jess, Klaus Theede, Susanne Hansen, Sandra Bohn Thomsen, Camilla B. Jensen, Lise Lotte Gluud, Marianne Kiszka-Kanowitz, Anette Mertz Nielsen
Publikováno v:
Thomsen, S B, Allin, K H, Burisch, J, Jensen, C B, Hansen, S, Gluud, L L, Theede, K, Kiszka-Kanowitz, M, Nielsen, A M & Less, T 2020, ' Outcome of concomitant treatment with thiopurines and allopurinol in patients with inflammatory bowel disease : A nationwide Danish cohort study ', European Journal of Gastroenterology and Hepatology, vol. 8, no. 1, pp. 68-76 . https://doi.org/10.1177/2050640619868387
BACKGROUND: Thiopurine and allopurinol in combination are associated with clinical remission in inflammatory bowel diseases but their influence on subsequent outcomes is unclear. We compared outcomes during exposure to both thiopurines and allopurino
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79b92c01a5531daae2b275fa57a40bd4
https://curis.ku.dk/portal/da/publications/outcome-of-concomitant-treatment-with-thiopurines-and-allopurinol-in-patients-with-inflammatory-bowel-disease(14d41a13-de3c-449d-8377-10f2f37d8f64).html
https://curis.ku.dk/portal/da/publications/outcome-of-concomitant-treatment-with-thiopurines-and-allopurinol-in-patients-with-inflammatory-bowel-disease(14d41a13-de3c-449d-8377-10f2f37d8f64).html
Autor:
Kristine H. Allin, Tine Jess, Mikael Andersson, Sandra Bohn Thomsen, Gry Poulsen, Jean-Frederic Colombel, Ryan C. Ungaro
Publikováno v:
Gastroenterology. 158:S-1207
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d573c905748aec4f8486323b9c26b26
https://doi.org/10.1016/s0016-5085(20)33681-7
https://doi.org/10.1016/s0016-5085(20)33681-7
Autor:
Marianne Kiszka-Kanowitz, Sandra Bohn Thomsen, Anette Mertz Nielsen, Lise Lotte Gluud, Klaus Theede
Publikováno v:
European journal of gastroenterologyhepatology. 30(10)
Objective Two meta-analyses have found that the risk of relapse in Crohn's disease (CD) was ~40 and 50% 1 and 2 years, respectively, after withdrawal of anti-tumour necrosis factor-α (anti-TNFα). The aim of this study was to evaluate relapse rates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e12630314e142ba0fee2382668b5075
https://pubmed.ncbi.nlm.nih.gov/29975242
https://pubmed.ncbi.nlm.nih.gov/29975242
Autor:
Ebbe Langholz, Julia Tua, Philip Grunert, Nik S. Ding, Nuha A. Yassin, Mathieu Uzzan, Javier P. Gisbert, Johan Burisch, Iago Rodríguez-Lago, Federica Furfaro, Sandra Bohn Thomsen, Nurulamin M Noor, A Cremer, Tamara Knezevic Ivanovski, Filip Baert, Eduards Krustins, Isabelle Cleynen, Britta Siegmund, Jurij Hanzel, Michael Scharl, Michail Galanopoulos, Neil O'Morain, Dominik Bettenworth
Background The 'United Registries for Clinical Assessment and Research' [UR-CARE] database is an initiative of the European Crohn's and Colitis Organisation [ECCO] to facilitate daily patient care and research studies in inflammatory bowel disease [I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::389f8d5248fcdebc09210d4765370e05
https://lirias.kuleuven.be/handle/123456789/619039
https://lirias.kuleuven.be/handle/123456789/619039
Autor:
Klaus Theede, Camilla B. Jensen, Johan Burisch, Sandra Bohn Thomsen, Anette Mertz Nielsen, Lise Lotte Gluud, T. Jess, Marianne Kiszka-Kanowitz, Susanne Hansen, Kristine H. Allin
Publikováno v:
Journal of Crohn's and Colitis. 13:S083-S083
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79369c417cf203ec8d5754627b188fce
https://doi.org/10.1093/ecco-jcc/jjy222.122
https://doi.org/10.1093/ecco-jcc/jjy222.122